Pressao Medical Completes Funding

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

September 23, 2020

Pressao Medical today announced the raising of additional private funding. The new investment will be used to continue product development, leading to a regulatory filing in various countries. The company is part of the portfolio of Adventus Ventures, LLC, a medical incubator and early-stage investor.

Pressao Medical has two products under development. The first is BP-ADJUST™, a new device in the form of a wristwatch that monitors blood pressure (BP) and heart rate and uses the information to deliver unique energy therapy to control BP. The second product is BP-ADJUST™ CV. This device uses the same technology, plus additional features that monitor vital diagnostic information, such as heart rate variability, ECG, heart arrhythmia, and oxygen level in combination with BP. The system is completely battery-operated, with rechargeable capabilities and wireless data communication.

BP-ADJUST™ and BP-ADJUST™ CV will be first-to-market devices of their kind to monitor and treat patients. Shawn Moaddeb says, “Our technology is truly unique, and it will be an absolute breakthrough as preventive therapy for prehypertensive patients and when used in combination with drugs in treating uncontrolled hypertension.”

Reza Allamehzadeh, M.D., chief medical officer at Pressao Medical and a hypertension and nephrology specialist says, “Overall prevalence of prehypertension in healthy adults is about 36% worldwide. Prehypertension, by itself, increases risk of heart disease by more than twofold. Prehypertensive patients have a 31% increased risk of coronary heart disease, 49% greater risk of stroke, and 44% greater risk of total cardiovascular events. By current guidelines, lifestyle modification is pursued over pharmacologic treatment (as currently there are no approved drugs for prehypertension) which may not completely lower the above risks. Reducing BP, even a few points, can make a significant impact.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.